Provided by Tiger Trade Technology Pte. Ltd.

Biofrontera Inc Warrant

0.0501
0.0000
Volume:- -
Turnover:- -
Market Cap:534.49K
PE:-0.03
High:0.0501
Open:0.0501
Low:0.0501
Close:0.0501
52wk High:0.2770
52wk Low:0.0251
Shares:10.67M
Float Shares:10.67M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8444
ROE:-325.31%
ROA:-35.18%
PB:0.03
PE(LYR):- -

Loading ...

Company Profile

Company Name:
Biofrontera Inc Warrant
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Website:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.